Follow
Joshua H. Choe
Joshua H. Choe
PhD Student, Harvard University
Verified email at g.harvard.edu - Homepage
Title
Cited by
Cited by
Year
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition
J Goodwin, ML Neugent, SY Lee, JH Choe, H Choi, DMR Jenkins, ...
Nature Communications 8 (1), 15503, 2017
1522017
p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas
MH Hsieh, JH Choe, J Gadhvi, YJ Kim, MA Arguez, M Palmer, H Gerold, ...
Cell Reports 28 (7), 1860-1878. e9, 2019
682019
Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers
C Katz, AM Low-Calle, JH Choe, O Laptenko, D Tong, ...
Genes & Development 32 (5-6), 430-447, 2018
342018
Li–Fraumeni syndrome–associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death
JH Choe, T Kawase, A Xu, A Guzman, AZ Obradovic, AM Low-Calle, ...
Cancer Discovery 13 (5), 1250-1273, 2023
52023
Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas
JH Choe, S Mazambani, TH Kim, J Kim
Cells 10 (3), 606, 2021
52021
Abstract LB361: Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death
JH Choe, T Kawase, A Xu, A Guzman, DR Tong, AZ Obradovic, ...
Cancer Research 83 (8_Supplement), LB361-LB361, 2023
2023
Targeting the glucose-insulin link in head and neck squamous cell carcinoma induces cytotoxic oxidative stress and inhibits cancer growth
S Mazambani, JH Choe, TG Oh, PK Singh, J Kim, TH Kim
bioRxiv, 2023.07. 13.548944, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–7